Al Altomari
Vorstandsvorsitzender bei AGILE THERAPEUTICS, INC.
Vermögen: 729 220 $ am 30.04.2024
Aktive Positionen von Al Altomari
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AGILE THERAPEUTICS, INC. | Vorsitzender | 01.10.2016 | - |
Vorstandsvorsitzender | 01.10.2010 | - | |
Direktor/Vorstandsmitglied | 01.02.2004 | 01.10.2016 | |
Präsident | 01.10.2010 | 01.10.2016 | |
Drexel University | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | - | - |
Karriereverlauf von Al Altomari
Ehemalige bekannte Positionen von Al Altomari
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SOCIETAL CDMO, INC. | Direktor/Vorstandsmitglied | 13.03.2014 | 06.03.2021 |
Independent Dir/Board Member | 13.03.2014 | 06.03.2021 | |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Direktor/Vorstandsmitglied | 01.04.2008 | 18.04.2011 |
Vorstandsvorsitzender | 01.04.2008 | 18.04.2011 | |
Geschäftsführer | 01.08.2003 | 01.04.2008 | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direktor/Vorstandsmitglied | - | - |
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Direktor/Vorstandsmitglied | 29.07.2010 | - |
Independent Dir/Board Member | 29.07.2010 | - | |
AUXILIUM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 06.12.2005 | - |
Independent Dir/Board Member | 31.10.2011 | - |
Ausbildung von Al Altomari
Drexel University | Undergraduate Degree |
Rider University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director/Board Member | 12 |
Independent Dir/Board Member | 4 |
Chairman | 3 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AGILE THERAPEUTICS, INC. | Health Technology |
SOCIETAL CDMO, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Auxilium Pharmaceuticals LLC
Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
- Börse
- Insiders
- Al Altomari
- Erfahrung